Login to Your Account

Pharma: Other news to note

Monday, January 27, 2014
Valeant Pharmaceuticals International Inc., of Laval, Quebec, completed the previously announced transaction in which a wholly owned subsidiary of Valeant Pharmaceuticals International would acquire Solta Medical Inc. at a price of $2.92 per share in cash.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription